Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic comparison of propofol + ketamine versus etomidate for anesthesia induction in low ejection fraction CABG patients
IRCT201207184365N14Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronary arteriosclerosis and heart failure with reduced ejection fraction (HFrEF) comparing Propofol + ketamine induction with Etomidate induction (2 arms). Primary endpoint: Peri-induction hemodynamic parameters. Started Sep 2012; status: completed.
02
Drugs
propofolketamineetomidate
03
Conditions
coronary arteriosclerosisheart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on IRCT201207184365N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201207184365N14.